LCT share purchase plan raises $1.08m
LCT share purchase plan raises $1.08m
Living Cell Technologies Limited today announced completion of its share purchase plan by the issue of 17,564,993 fully paid ordinary shares, raising an additional $1.08m. The shares will be allotted on 8 December 2014.
The share purchase plan gave all shareholders in Australia and New Zealand the opportunity to participate in the success of the company on the same basis as the $3m private placement, which was completed in October. The $4.08m total raised is projected to provide funding for the company’s development program into 2016.
The CEO, Dr Ken Taylor said, “This is an excellent result and demonstrates shareholder confidence in our development path of cell therapy for neurodegenerative diseases.”
– Ends –
Stats NZ: Economic Impacts On New Zealand From Conflict In The Middle East – Report
Advertising Standards Authority: ASA Annual Report 2025 - Platform-Neutral Regulation Keeps Pace With Digital Advertising
Science Media Centre: Lead Pipes Banned For New Plumbing – Expert Reaction
New Zealand Young Physicists Trust: Auckland To Host The ‘World Cup Of Physics’ In 2027; Search Begins For Student-Designed Tournament Logo
Oxfam Aotearoa: Top CEO Pay Increased 20 Times Faster Than Workers’ Pay In 2025
Bill Bennett: TUANZ Report - Networks Built, Value Missing

